MDM2 and Miyoshi myopathy: Consistently, we found that MX69 treatment in MM cells efficiently inhibited MM cell proliferation, cell cycle progression, colony formation and migration, as well as induced apoptosis irrespective of p53 status by targeting the MDM2-c-Myc regulatory loop (Figure 8).